Y-Mabs Therapeutics Overview
Y-Mabs Therapeutics Target Price
Analysts' 12-month price predictions for YMAB.
Get informed when a big investor buys or sells
+ FollowShare Price
$8.61
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-08-05 | Morgan Stanley | $8.6 |  0.1% downside |  |
| 2025-08-05 | Canaccord Genuity | $8.6 | 0.1% downside | |
| 2025-08-05 | Truist Financial | $8.6 | 0.1% downside | |
| 2025-08-05 | Cantor Fitzgerald | $8.6 | 0.1% downside | |
| 2025-08-05 | Wedbush | $8.6 | 0.1% downside | |
| 2025-03-05 | Morgan Stanley | $7 | 18.7% downside | |
| 2024-11-11 | BMO CapitalEtzer Darout | $24 |  178.7% upside | |
| 2024-06-28 | Truist FinancialNicole Germino | $21 | 143.9% upside | |
| 2024-05-10 | H.C. WainwrightRobert Burns | $22 | 155.5% upside | |
| 2024-04-05 | BMO CapitalEtzer Darout | $26 | 202% upside | |
| 2023-05-10 | WedbushYMAB)to Outperform | $13 | 51% upside | |